Turn Therapeutics (Direct Listing)

Print
General Information
Business:

Note: This is a direct listing on the NASDAQ. This is NOT an IPO. The listing was filed under Global Health Solutions. The company is changing its name to Turn Therapeutics. Existing stockholders are selling the stock in the direct listing. The company is not raising new capital.

We are focused on wound care and dermatology. We are working on getting FDA approval for a new formula of Hexagen to treat eczema and onychomycosis (fungal infection of the nails).

(Note: The registered stockholders of Turn Therapeutics (aka Global Health Solutions) plan to sell up to 17.87 million shares, according to an S-1/A filing dated Sept. 29, 2025. Background: In its S-1 filing, Turn Therapeutics said its registered stockholders planned to sell up to 8.9 million shares. Note: Clear Street is the financial advisor. A direct listing does not have an underwriter. A reference price  has not been published.) 
.

 
Industry: Pharmaceuticals
Employees: 2
Founded: 2015
Contact Information
Address 250 N. Westlake Blvd. Westlake Village, CA 91362
Phone Number (818) 564-4011
Web Address https://turntherapeutics.com/
View Prospectus: Turn Therapeutics (Direct Listing)
Financial Information
Market Cap
Revenues $0 mil (last 12 months)
Net Income $-2.59 mil (last 12 months)
IPO Profile
Symbol TTRX
Exchange NASDAQ
Shares (millions): 17.9
Price range $0.00 - $0.00
Est. $ Volume $0.0 mil
Manager / Joint Managers Clear Street
CO-Managers
Expected To Trade: 10/13/2025
Day: Week of
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change